Product Information
ROCKLATAN 0.02%-0.005% EYE DRP is a brand product labeled by Alcon Laboratories, Inc., priced at $139.4419 per ML under NDC 70727052925. Its NADAC has been published 366 times since Aug 21, 2019.
FDA first approved this application on Mar 12, 2019.
ROCKLATAN 0.02%-0.005% EYE DRP
netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%Strength
.05; .2 mg/mL; mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
70727052925
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC; TOPICAL
Effective Date
8/19/2026
Active Ingredients
LATANOPROST; NETARSUDIL MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA208259FDA Approved
3/12/2019
On Market Since
3/12/2019
Pharmacological Classes
Price Statistics
The NADAC for ROCKLATAN 0.02%-0.005% EYE DRP has been published 366 times since Aug 21, 2019, and over the history we have for it it has risen 38.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $139.4419 per ML |
|---|---|
| All-time high | $139.6392 (May 13, 2026) |
| All-time low | $100.5940 (Aug 21, 2019) |
| 52-week high | $139.6392 |
| 52-week low | $135.4742 |
| Median price | $126.6973 |
| Average price | $123.8061 |
| Largest weekly change | +9.0% (Oct 2, 2019) |
| Weeks tracked | 366 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROCKLATAN 0.02%-0.005% EYE DRP?
The current National Average Drug Acquisition Cost (NADAC) for ROCKLATAN 0.02%-0.005% EYE DRP, manufactured by Alcon Laboratories, Inc., is $139.4419 per ML (NDC 70727052925), effective Aug 19, 2026.
How has the price of ROCKLATAN 0.02%-0.005% EYE DRP changed over time?
Over the history we have for it, the NADAC for ROCKLATAN 0.02%-0.005% EYE DRP has risen 38.6%. It has been tracked across 366 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for ROCKLATAN 0.02%-0.005% EYE DRP?
Since Aug 21, 2019, the NADAC for ROCKLATAN 0.02%-0.005% EYE DRP has ranged from a low of $100.5940 (Aug 21, 2019) to a high of $139.6392 (May 13, 2026), with a median of $126.6973 per ML.
Are there cheaper alternatives to ROCKLATAN 0.02%-0.005% EYE DRP?
No other NADAC-published product currently shares the active ingredient and strength of ROCKLATAN 0.02%-0.005% EYE DRP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROCKLATAN 0.02%-0.005% EYE DRP?
ROCKLATAN 0.02%-0.005% EYE DRP (NDC 70727052925) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.